GRCL News and Press, Gracell Biotechnologies Inc. From 07/26/22

Gracell Biotechnologies to Participate in BTIG 2022 Biotechnology Conference PR Newswire SAN DIEGO, Calif. , and SUZHOU and SHANGHAI, China , July 26, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global cli...

Gracell Biotechnologies ( NASDAQ: GRCL ) has announced the appointment of Samuel Zhang, Ph.D., as its Chief Business Officer. In this role, Dr. Zhang will be responsible for strategic leadership of Gracell's global business development and corporate strategy, including str...

Gracell Biotechnologies Appoints Veteran BioPharma Executive Dr. Samuel Zhang as Chief Business Officer PR Newswire SAN DIEGO, Calif. and SUZHOU and SHANGHAI, China , July 19, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Compan...

Gainers: Seritage Growth Properties ( SRG ) +72% . Aditxt ( ADTX ) +70% . Humanigen ( HGEN ) +35% . Clovis Oncology ( CLVS ) +30% . MyMD Pharmaceuticals ( MYMD ) +27% . Oramed Pharmaceuticals ( ORMP ) +26% . Kura ...

Day One Biopharmaceuticals (DAWN) +81% announces positive initial data from pivotal FIREFLY-1 trial of Tovorafenib (DAY101) in relapsed pediatric low-grade Glioma. Redbox Entertainment (RDBX) +30%. Ekso Bionics Holdings (EKSO) +22% receives FDA clearance to market its EksoNR Robotic...

Gracell Biotechnologies Presents Updated Clinical Data for BCMA/CD19 Dual-targeting FasTCAR GC012F in RRMM at EHA2022 Congress, Highlighting 100% MRD Negativity Rate in All Treated Patients PR Newswire Gracell also presented data on GC012F for treatment of B-NHL and al...

Gracell Biotechnologies Schedules Clinical Update Call After EHA2022 To hold conference call on Monday, June 13 at 8:00 am ET PR Newswire SAN DIEGO, Calif. and SUZHOU and SHANGHAI, China , June. 3, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NA...

Gracell Biotechnologies to Present Updated Clinical Data on BCMA/CD19 Dual-Targeting CAR-T GC012F for Relapsed/Refractory Multiple Myeloma at 2022 ASCO Annual Meeting PR Newswire SAN DIEGO, Calif. and SUZHOU and SHANGHAI, China , May 26, 2022 /PRNewsw...

Gracell Biotechnologies to Participate in Three Upcoming Investor Conferences PR Newswire SAN DIEGO, Calif. , SUZHOU and SHANGHAI, China , May 19, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmac...

Gracell Biotechnologies Inc. (GRCL) Q1 2022 Earnings Conference Call May 16, 2022 8:00 a.m. ET Company Participants Dr. William Cao - Founder, Chairman, and CEO Dr. Martina Sersch - CMO Dr. Kevin Xie - CFO Conference Call Participants Joe Catanzaro - Piper Sandler Kelly Shi - Jefferies Nick A...